Additional file 1: of MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis Antonio Uccelli Alice Laroni Lou Brundin Michel Clanet Oscar Fernandez Seyed Nabavi Paolo Muraro Roberto Oliveri Ernst Radue Johann Sellner Per Soelberg Sorensen Maria Sormani Jens Wuerfel Mario Battaglia Mark Freedman 10.6084/m9.figshare.8105831.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_MEsenchymal_StEm_cells_for_Multiple_Sclerosis_MESEMS_a_randomized_double_blind_cross-over_phase_I_II_clinical_trial_with_autologous_mesenchymal_stem_cells_for_the_therapy_of_multiple_sclerosis/8105831 SPIRIT 2013 checklist: Recommended items to address in a clinical trial protocol and related documents. (DOC 256 kb) 2019-05-09 05:00:00 Multiple sclerosis Mesenchymal stem cells Mesenchymal stromal cells Clinical trial